These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 19437339)

  • 21. Platelet activation patterns are different in mouse models of diabetes and chronic inhibition of nitric oxide synthesis.
    Rozalski M; Kassassir H; Siewiera K; Klepacka A; Sychowski R; Watala C
    Thromb Res; 2014 Jun; 133(6):1097-104. PubMed ID: 24731558
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of platelet activation in vitro by the c-Mpl ligand, thrombopoietin.
    Chen J; Herceg-Harjacek L; Groopman JE; Grabarek J
    Blood; 1995 Dec; 86(11):4054-62. PubMed ID: 7492761
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cilostazol inhibits platelet-leukocyte interaction by suppression of platelet activation.
    Ito H; Miyakoda G; Mori T
    Platelets; 2004 Aug; 15(5):293-301. PubMed ID: 15370100
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spontaneous platelet aggregation evaluated by laser light scatter in patients with type 2 diabetes: effects of short-term improved glycemic control and adiponectin.
    Hara K; Omori K; Sumioka Y; Aso Y
    Transl Res; 2012 Jan; 159(1):15-24. PubMed ID: 22153806
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High glucose levels enhance platelet activation: involvement of multiple mechanisms.
    Sudic D; Razmara M; Forslund M; Ji Q; Hjemdahl P; Li N
    Br J Haematol; 2006 May; 133(3):315-22. PubMed ID: 16643434
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation between albuminuria and spontaneous platelet microaggregate formation in type 2 diabetic patients.
    Araki S; Matsuno H; Haneda M; Koya D; Kanno Y; Itho J; Kishi A; Isshiki K; Sugimoto T; Maegawa H; Kashiwagi A; Uzu T
    Diabetes Care; 2009 Nov; 32(11):2062-7. PubMed ID: 19675198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loxosceles gaucho spider venom and its sphingomyelinase fraction trigger the main functions of human and rabbit platelets.
    Tavares FL; Peichoto ME; Rangel Dde M; Barbaro KC; Cirillo MC; Santoro ML; Sano-Martins IS
    Hum Exp Toxicol; 2011 Oct; 30(10):1567-74. PubMed ID: 21247992
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relative and absolute changes of activated platelets, microparticles and platelet aggregates after activation in vitro.
    Matzdorff AC; Berchner D; Kühnel G; Kemkes-Matthes B; Pralle H; Voss R
    Haemostasis; 1998; 28(6):277-88. PubMed ID: 10461010
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelet microparticles and soluble P selectin in peripheral artery disease: relationship to extent of disease and platelet activation markers.
    Tan KT; Tayebjee MH; Lynd C; Blann AD; Lip GY
    Ann Med; 2005; 37(1):61-6. PubMed ID: 15902848
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protease-activated receptor-4 (PAR4) variant influences on platelet reactivity induced by PAR4-activating peptide through altered Ca
    Morikawa Y; Kato H; Kashiwagi H; Nishiura N; Akuta K; Honda S; Kanakura Y; Tomiyama Y
    Thromb Res; 2018 Feb; 162():44-52. PubMed ID: 29289806
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platelet activation by 2-(4-bromo-2,3-dioxobutylthio)adenosine 5'-diphosphate is mediated by its binding to a putative ADP receptor, aggregin.
    Puri RN; Colman RF; Colman RW
    Eur J Biochem; 1996 Mar; 236(3):862-70. PubMed ID: 8665907
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of calcium-dependent calmodulin by calcium(II)3(3,5-diisopropylsalicylate)6(H2O)6 decreases thrombin receptor activating peptide-induced P-selectin expression.
    Homoncik M; Jilma B; Donham DC; Frossard M; Keuzer C; Sorenson JR
    Blood Coagul Fibrinolysis; 2003 Feb; 14(2):131-8. PubMed ID: 12632022
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Influence of prothrombin cleavage products on platelet activation and aggregation].
    Korol'ova DS; Chernyshenko VO; Hornyts'ka OV; Platonova TM
    Ukr Biokhim Zh (1999); 2009; 81(5):58-65. PubMed ID: 20387648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelet function and microparticle levels in atrial fibrillation: Changes during the acute episode.
    Pourtau L; Sellal JM; Lacroix R; Poncelet P; Bernus O; Clofent-Sanchez G; Hocini M; Haïssaguerre M; Dignat-George F; Sacher F; Nurden P
    Int J Cardiol; 2017 Sep; 243():216-222. PubMed ID: 28747025
    [TBL] [Abstract][Full Text] [Related]  

  • 35. p42 mitogen-activated protein kinase and p90 ribosomal S6 kinase are selectively phosphorylated and activated during thrombin-induced platelet activation and aggregation.
    Papkoff J; Chen RH; Blenis J; Forsman J
    Mol Cell Biol; 1994 Jan; 14(1):463-72. PubMed ID: 8264614
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Salvianolic acid a inhibits platelet activation and aggregation in patients with type 2 diabetes mellitus.
    Zhou AM; Xiang YJ; Liu EQ; Cai CH; Wu YH; Yang LB; Zeng CL
    BMC Cardiovasc Disord; 2020 Jan; 20(1):15. PubMed ID: 31931718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protein phosphatase inhibitor calyculin-A modulates activation markers in TRAP-stimulated human platelets.
    Simon Z; Kiss A; Erdödi F; Setiadi H; Beke Debreceni I; Nagy B; Kappelmayer J
    Platelets; 2010; 21(7):555-62. PubMed ID: 20670106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Inhibiting effect of adenosine on platelet activation in vitro].
    Wang DM; Liu JH; Zhou J; Ouyang XL; Xing YC
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Dec; 13(6):1094-8. PubMed ID: 16403288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantifying the effects of shear stress and shear exposure duration regulation on flow induced platelet activation and aggregation.
    Rubenstein DA; Yin W
    J Thromb Thrombolysis; 2010 Jul; 30(1):36-45. PubMed ID: 19834785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Platelet microparticles bind, activate and aggregate neutrophils in vitro.
    Jy W; Mao WW; Horstman L; Tao J; Ahn YS
    Blood Cells Mol Dis; 1995; 21(3):217-31; discussion 231a. PubMed ID: 8673474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.